| 1 |
Estimated global incidence of Japanese encephalitis:
Grant L. Campbell, Susan L. Hills, Marc Fischer et al. · Bulletin of the World Health Organization
Open access |
Oct 2011 |
1,013 |
| 2 |
Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine
Michael J. Roy, Mary S. Wu, Lori J. Barr et al. · Vaccine
|
Nov 2000 |
362 |
| 3 |
A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
Luis A. Brito et al. · Molecular Therapy
Open access |
16 Jul 2014 |
341 |
| 4 |
Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen
Tomáš Hanke, Rachel V. Samuel, Tom J. Blanchard et al. · Journal of Virology
Open access |
Sep 1999 |
306 |
| 5 |
Vaccines against invasiveSalmonelladisease
Calman Alexander MacLennan, Laura B. Martin, Francesca Micoli · Human Vaccines & Immunotherapeutics
Open access |
7 May 2014 |
208 |
| 6 |
Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239
Helen Horton, Thorsten U. Vogel, Donald K. Carter et al. · Journal of Virology
Open access |
15 Jul 2002 |
194 |
| 7 |
Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines
Daniela Amicizia, Alexander Domnich, Donatella Panatto et al. · Human Vaccines & Immunotherapeutics
Open access |
19 Feb 2013 |
194 |
| 8 |
DNA Vaccines Expressing either the GP or NP Genes of Ebola Virus Protect Mice from Lethal Challenge
Lorna Vanderzanden, Mike Bray, DEBORAH HEYDENBURG FULLER et al. · Virology
Open access |
Jun 1998 |
172 |
| 9 |
Towards the next generation of biomedicines by site-selective conjugation
Qiying Hu, Francesco Berti, Roberto Adamo · Chemical Society Reviews
ReviewOpen access |
2016 |
168 |
| 10 |
New generation adjuvants – From empiricism to rational design
Derek T. O’Hagan, Christopher B. Fox · Vaccine
|
26 May 2015 |
165 |
| 11 |
Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling Study
You Li, Durga Kulkarni, Elizabeth M. Begier et al. · Infectious Diseases and Therapy
ReviewOpen access |
20 Mar 2023 |
162 |
| 12 |
Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination
Scott T. Rottinghaus, Gregory A. Poland, Robert M. Jacobson et al. · Vaccine
|
30 Jun 2003 |
147 |
| 13 |
The vaccine adjuvant alum inhibits IL ‐12 by promoting PI 3 kinase signaling while chitosan does not inhibit IL ‐12 and enhances T h1 and T h17 responses
Andrés Mori, Ewa Oleszycka, Fiona A. Sharp et al. · European Journal of Immunology
|
10 Jul 2012 |
142 |
| 14 |
DNA Immunization with Minigenes: Low Frequency of Memory Cytotoxic T Lymphocytes and Inefficient Antiviral Protection Are Rectified by Ubiquitination
Fernando A. Rodriguez, Ling An, Stephanie S. Harkins et al. · Journal of Virology
Open access |
Jun 1998 |
142 |
| 15 |
Combination Vaccines
DavidAG Skibinski, BarbaraC Baudner, Manmohan Singh et al. · Journal of Global Infectious Diseases
Open access |
2011 |
128 |
| 16 |
Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines
Gail L. Rodgers, Adriano G Arguedas, Robert W. Cohen et al. · Vaccine
|
26 Apr 2009 |
125 |
| 17 |
Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
Francesca Micoli, Simona Rondini, Renzo Alfini et al. · Proceedings of the National Academy of Sciences
Open access |
27 Sep 2018 |
123 |
| 18 |
Induction of Mucosal Protection against Primary, Heterologous Simian Immunodeficiency Virus by a DNA Vaccine
DEBORAH HEYDENBURG FULLER, Premeela A. Rajakumar, Lawrence Wilson et al. · Journal of Virology
Open access |
Apr 2002 |
114 |
| 19 |
Global vaccine action plan lessons learned I: Recommendations for the next decade
Noni MacDonald, Ezzeddine Mohsni, Yagob Y. Al-Mazrou et al. · Vaccine
Open access |
4 May 2020 |
110 |
| 20 |
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
Sandra J. Bliss, Katherine L. O'Flynn O'Brien, Edward N. Janoff et al. · The Lancet Infectious Diseases
|
4 Dec 2007 |
110 |
| 21 |
Dissolvable Microneedle Patches for the Delivery of Cell-Culture-Derived Influenza Vaccine Antigens
Sushma Kommareddy, Barbara C. Baudner, Seajin Oh et al. · Journal of Pharmaceutical Sciences
|
20 Dec 2011 |
107 |
| 22 |
Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial
Suzanne Marie Garland et al. · International Journal of Cancer
Open access |
19 Aug 2016 |
105 |
| 23 |
Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications
Omar Rossi, Isabella Pesce, Carlo Giannelli et al. · Journal of Biological Chemistry
Open access |
15 Jul 2014 |
105 |
| 24 |
Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime
T Hanke, Veronica C. Neumann, Tom J. Blanchard et al. · Vaccine
|
Feb 1999 |
105 |
| 25 |
Multispecific Vaccine-Induced Mucosal Cytotoxic TLymphocytes Reduce Acute-Phase Viral Replication but Fail inLong-Term Control of Simian Immunodeficiency VirusSIVmac239
Thorsten U. Vogel, Matthew R. Reynolds, DEBORAH HEYDENBURG FULLER et al. · Journal of Virology
Open access |
25 Nov 2003 |
102 |
| 26 |
Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
Raphaël M. Zellweger, Robyn Miller, William E. Eddy et al. · PLoS Pathogens
Open access |
31 Oct 2013 |
102 |
| 27 |
Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection
Alvaro Baeza Garcia, Edwin Siu, Tiffany Sun et al. · Nature Communications
Open access |
9 Jul 2018 |
100 |
| 28 |
Stabilization of Alum-Adjuvanted Vaccine Dry Powder Formulations: Mechanism and Application
Yuh‐Fun Maa, Lu Jie Zhao, Lendon G. Payne et al. · Journal of Pharmaceutical Sciences
|
17 Jan 2003 |
100 |
| 29 |
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
Viswanathan Ramasamy, Upasana Arora, Rahul Shukla et al. · PLoS neglected tropical diseases
Open access |
8 Jan 2018 |
97 |
| 30 |
Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin fromEscherichia coliAre Strong Adjuvants for DNA Vaccines
Joshua Arrington, Ralph Peter Braun, Lichun Dong et al. · Journal of Virology
Open access |
May 2002 |
88 |
| 31 |
MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020)
Barbara C. Baudner, Vanessa Ronconi, Daniele Casini et al. · Pharmaceutical Research
|
2 Mar 2009 |
87 |
| 32 |
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence
Darron R. Brown, Elmar Armin Joura, Glorian Yen et al. · Vaccine
Review |
19 Mar 2021 |
84 |
| 33 |
Varicella-Zoster Virus Infection Induces Autophagy in both Cultured Cells and Human Skin Vesicles
M Takahashi, Wallen Jackson, Donna T. Laird et al. · Journal of Virology
Open access |
19 Mar 2009 |
81 |
| 34 |
IL-15 transpresentation promotes both human T-cell reconstitution and T-cell–dependent antibody responses in vivo
Nicholas D. Huntington, Nuno L. Alves, Nicolas Legrand et al. · Proceedings of the National Academy of Sciences
Open access |
28 Mar 2011 |
81 |
| 35 |
Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination
Rodrigo B. Abreu, Greg A. Kirchenbaum, Emily F. Clutter et al. · JCI Insight
Open access |
3 Dec 2019 |
78 |
| 36 |
An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection
Laura White, Carlos A. Sariol, Melissa D. Mattocks et al. · Journal of Virology
Open access |
10 Jan 2013 |
75 |
| 37 |
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial
Wendy A. Keitel, Nicola Groth, Maria Lattanzi et al. · Vaccine
|
15 Oct 2009 |
73 |
| 38 |
Epidermal Powder Immunization Induces both Cytotoxic T-Lymphocyte and Antibody Responses to Protein Antigens of Influenza and Hepatitis B Viruses
Dexiang Chen, Kathleen F. Weis, Qili Chu et al. · Journal of Virology
Open access |
Dec 2001 |
72 |
| 39 |
The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
Vanessa Racloz, Silva JD Luiz · BMC Infectious Diseases
ReviewOpen access |
17 Jun 2010 |
70 |
| 40 |
Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis
Hansi J. Dean, DEBORAH HEYDENBURG FULLER, Jorge E. Osorio · Comparative Immunology Microbiology and Infectious Diseases
|
23 Apr 2003 |
68 |
| 41 |
Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization
Dexiang Chen, S. Bhargava Periwal, Katherine Larrivee et al. · Journal of Virology
Open access |
Sep 2001 |
68 |
| 42 |
Development of Pandemic Vaccines: ERVEBO Case Study
Jayanthi J. Wolf, Risat Jannat, Sheri A. Dubey et al. · Vaccines
Open access |
25 Feb 2021 |
67 |
| 43 |
A systematic literature review to assess the burden of herpes zoster disease in China
Dapeng Yin, Desirée Van Oorschot, Ning Jiang et al. · Expert Review of Anti-infective Therapy
ReviewOpen access |
30 Sep 2020 |
66 |
| 44 |
Coadministration of DNA Encoding Interleukin-6 and Hemagglutinin Confers Protection from Influenza Virus Challenge in Mice
Diane L. Larsen, Naomi Dybdahl-Sissoko, Martha W. McGregor et al. · Journal of Virology
Open access |
Feb 1998 |
66 |
| 45 |
Comparison of Immunity Generated by Nucleic Acid-, MF59-, and ISCOM-Formulated Human Immunodeficiency Virus Type 1 Vaccines in Rhesus Macaques: Evidence for Viral Clearance
Ernst J. Verschoor, Petra Mooij, Herman Oostermeijer et al. · Journal of Virology
Open access |
Apr 1999 |
65 |
| 46 |
Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data
Stefania Vergnano et al. · Vaccine
Open access |
3 Aug 2016 |
62 |
| 47 |
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
Francesca Micoli, Maria Rosaria Romano, Marta Tontini et al. · Proceedings of the National Academy of Sciences
Open access |
4 Nov 2013 |
62 |
| 48 |
Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination
G Soboll, D.W. Horohov, Brian M Aldridge et al. · Veterinary Immunology and Immunopathology
|
3 Jun 2003 |
62 |
| 49 |
Adjuvantation of epidermal powder immunization
Dexiang Chen, Cherie A. Erickson, Ryan L. Endres et al. · Vaccine
|
Apr 2001 |
61 |
| 50 |
The impact of the COVID-19 pandemic on vaccination uptake in the United States and strategies to recover and improve vaccination rates: A review
Luke Cunniff, Elif Alyanak, Alessandra Fix et al. · Human Vaccines & Immunotherapeutics
Open access |
Aug 2023 |
60 |